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EQ IFACTS
Control of Infectious Diseases of Horses
Doyle G. Meadows, Professor, Animal Science
John E. Henton, Professor, Large Animal Clinical Sciences, College of Veterinary Medicine
An effective disease control program is
extremely important to maintain the health
and usefulness of a horse. A disease control
program is just part of a total management
scheme of proper health, nutrition, reproduction, growth and performance. A healthy, disease-free horse will have the opportunity to
maximize its genetic potential or simply carry
the horse owner on a Sunday afternoon pleasure ride. This fact sheet will provide Tennessee horse owners information about diseases
and their control.

Equine Encephalomyelitis
Equine encephalomyelitis is a viral disease
which causes degeneration in certain areas of
the brain. This disease is commonly referred
to as sleeping sickness. It affects horses and
is a threat to humans as well. Eastern Equine
Encephalomyelitis (EEE) and Western Equine
Encephalomyelitis (WEE) are diagnosed in the
United States. Venezuelan Equine Encephalomyelitis (VEE) is present in South and Central
America. The disease is transmitted to horses
primarily by mosquitoes from wild birds and
rodents, which serve as carriers.
The amount of virus in the blood of
horses affected with EEE and WEE is very
low and makes horse-to-human transmission very unlikely. This is not the case with
VEE. Therefore, VEE presents a much greater
public health threat. Multiple horses may become affected. This indicate that the horses
are susceptible and that the insects in the

area are carrying the virus. The death rate for
WEE is approximately 50 percent, while EEE
and VEE have death rates of 70 percent to 90
percent.
Symptoms of the disease actually occur
in four stages. Stage I is characterized by an
extremely high body temperature for a short
period of time. In addition, nervous signs appear at peak of fever, with the horse being
very sensitive to sound. In stage II, the horse
shows signs of depression and drowsiness as
well as abnormal gait and circling. The horse
in stage III shows signs of paralysis. Typically,
the horse cannot raise its head, the lower lip
drops and the tongue may hang out. Complete
paralysis and death occur in stage IV.
An effective vaccination program is available to prevent Equine encephalomyelitis.
Many vaccines are available and can be secured from veterinarians. Vaccinations will
include a two-shot series, four to six weeks
apart, for an unvaccinated horse. Thereafter,
annual vaccination is recommended in the
spring or early summer. Horses in the extreme Southern United States should be vaccinated semi-annually. Many Tennessee horse
owners also have started a semi-annual vaccination program. Foals may be started on
a vaccination program at 2-3 months of age.
This vaccine is often combined with other vaccines like tetanus toxoid.
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Tetanus
Tetanus is a usually fatal bacterial disease
which poses a continual threat to horses. This
clostridial bacteria is present in all equine
manure, and horses have an unusually high
susceptibility to the disease. The mortality
of affected horses is greater than 80 percent.
Protective immunization against this disease
is mandatory.
Clostridium tetani bacteria prefer an environment low in oxygen, which allows the
bacteria to multiply and produce toxins.
Therefore, deep wounds (puncture wounds)
are the most dangerous. The bacteria produce
spores which can live in the environment for
years and often enter the body on rusty nails
or wire. The toxins interfere with the nervous
system of the animal, resulting in a very tight,
stiff muscles. Other clinical signs include a
stiff, stilted gait, elevated tail, persistent protrusion of the third eyelid and a classical
“sawhorse” stance. As the disease progresses,
most horses will be unable to eat or drink and
generally die of respiratory paralysis.
Two products are available for protecting
horses against tetanus. These are tetanus antitoxin and tetanus toxoid. Tetanus antitoxin
gives immediate but short lived protection. It
is given to horses not previously vaccinated
that have a wound or to newborn foals from
unvaccinated mares. Tetanus toxoid gives
long-acting protection but takes two weeks for
the protection to develop after the initial vaccination series is given. This vaccine is given
as two shots, one month apart, followed by a
yearly booster. Foals can be given the vaccine
beginning at 3 months of age. Pregnant mares
should be given the vaccine one month before
foaling, and any horse with an injury or having surgery should be given a booster.

Equine Influenza
The influenza virus is the most common
cause of respiratory disease in horses. Influenza is caused by two specific types of viruses
— myxovirus A/Equi and myxovirus A/Equi 2.
The disease is highly contagious and is spread
by horses coughing and others breathing the
droplets as they move through the air. A horse
infected with the virus can cough and spread
the virus as far as 35 feet. The virus settles
on feed, feed buckets, etc. and is eaten or
breathed in by the horse. Isolation of affected
horses is essential

Clinical signs of the disease include high
body temperature (101 to 106 F), runny nose,
depression, cough and loss of appetite. The
incubation period for this disease can be very
short — one to five days. This disease can initiate other secondary disease processes like
pneumonia, laminitis and colic. It is essential
to give adequate rest of three to four weeks
to allow complete regeneration of the upper
respiratory tract. If a horse is not properly
rested, secondary bacterial infection could
result. These secondary infections could be
much more severe than the influenza virus
itself. Chronic Obstructive Pulmonary Disease
(Heaves) may often result from severe cases of
influenza.
Vaccines for equine influenza are available
to the veterinarian from many manufacturers. These vaccines provide adequate protection for only 60 to 90 days. It is recommended
that horses at substantial risk of exposure to
the virus (show horses, race horses, horses
at boarding stables, etc.) be vaccinated every
60 to 90 days. Horses with little exposure to
other horses may not require vaccinations or
might receive them annually or semi-annually. This vaccine is often combined with other
vaccines for tetanus, EEE, WEE and rhinopneumonitis. Mare should be vaccinated one
month prior to foaling.

Rhinopneumonitis
Rhinopneumonitis is a herpes virus infection that affects all ages of horses. This virus
can cause several different syndromes in the
horse. The respiratory form has clinical signs
very similar to equine influenza (fever, cough,
nasal discharge). Its mode of transmission
is also similar. The abortion form will cause
abortion in late pregnancy and will cause
weak or stillborn foals. The neurologic form
of the disease may cause rear limb ataxia or
even paralysis. There are two vaccines available to protect horse against rhinopneumonitis virus, modified live and killed. These
vaccines can be given to horses 3 months
old and older for protection against the respiratory and abortion forms of the disease.
Pregnant mares should be vaccinated for rhinopneumonitis at the fifth, seventh and ninth
months of pregnancy to give them the best
protection against abortion.
For protection against the respiratory form
of the disease, high-risk horses should receive

4001.2

vaccinations at 60-to 90-day intervals. This
is similar to the recommendation for equine
influenza. Combination vaccines with equine
rhinopneumonitis are now available which allow easy immunization against both respiratory viruses.

Strangles
Strangles is a highly communicable bacterial disease primarily affecting young horses,
although older horses may contract the disease. The bacterial organism causes inflammation of the upper respiratory tract, and the
lymph glands in the jaw and throat area become enlarged and swollen. Strangles is also
known as distemper or shipping fever.
The disease can be spread by nasal discharge that contaminates water troughs,
feed bunks or pastures. Once the bacteria
are present, they are persistent in the area
for years. Horses also develop varying degrees of immunity once they have contracted
strangles.
Symptoms of the disease are high body
temperature (103 to 104 F), swollen lymph
glands, nasal discharge, cough and difficulty
in swallowing. The lymph glands may abscess
and burst. After rupture, the glands will produce a thick, cream-colored discharge. Some
horses may develop pneumonia or internal
abscesses.
Treatment recommendations for strangles
may vary with each farm outbreak. Consult your veterinarian at the first possibility
of the disease. All horses brought to a horse
farm should be quarantined and all sick animals isolated. All feed buckets, water troughs,
brushes, halters and other equipment or facilities that come into contact with infected
horses should be disinfected.
A vaccine for strangles is available; however, many veterinarians only vaccinate
horses where there is a recurring problem or
direct exposure. The vaccine must be given in
three doses, two weeks apart, followed by an
annual booster. There have been reports of
vaccine failures and abscesses occurring at
the injection sites. As a result, this vaccine is
best used under the supervision and advice
of a veterinarian familiar with the horses or
farm having problems with strangles.

Potomac Horse Fever
Potomac Horse Fever was identified in
1979. The disease was first described in those

states near the Potomac River (Virginia, Maryland, Pennsylvania). This disease now appears to be most prevalent in the Eastern
United States but has been identified in 33
states. The disease appears to be associated
with rivers or large bodies of water. The causative agent has been identified with a group
of organisms which includes the one causing
Rocky Mountain Spotted Fever. However, it is
not the same organism.
Symptoms of the disease include mild depression, refusal to eat, increased body temperature and stoppage of intestinal movement.
In many cases, a profuse watery diarrhea
develops which leads to rapid dehydration.
Laminitis often occurs secondarily to the disease. Most cases occur between March and
October. Factors which are still unknown
about Potomac Horse Fever include the mode
of transmission, cause of the diarrhea and
the high incidence of laminitis. Twenty-five
to 30 percent of affected animals die. A significant number of the horses that no not die
will be permanently affected from secondary
laminitis.
Vaccines are available for the control of
this disease; a two-shot series at four to six
week intervals is recommended for non-vaccinated horses. Annual boosters in the spring
are recommended for previously vaccinated
horses. Vaccination can begin at 3 months of
age and can also be given to pregnant mares
one month prior to foaling.

Rabies
Rabies is a viral disease that is fatal to
horses. Rabies is the result of an infected wild
animal biting a horse on the muzzle, face or
lower limb. Although rabies is not a major
problem in most areas of Tennessee, horses
which may have contact with wildlife should
be vaccinated. A vaccine is available for use
in the horse, and annual boosters are recommended for horses in areas where rabies is a
problem.

Equine Infectious Anemia
Equine infectious anemia (EIA) is a viral disease affecting less than 1 percent of
the horse population in Tennessee. The recognized test for EIA is the agar-gel immunodiffusion (AGID) test developed by LeeRoy
Coggins. The test is not actually for the EIA
virus but for antibodies developed to fight the
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disease. A horse that reacts positively to the
test is classified as a carrier. The test is simple
and accurate.
This viral disease has some unique characteristics. It is specific for the equine family
(horse, ponies, mules), the infection is permanent and there is no known cure. Furthermore, there is no preventive vaccine available
to horse owners. Horses may show no signs of
the disease or may die a few days after symptoms appear.
EIA is transmitted “blood-to-blood” by
blood-sucking insects (flies and mosquitoes)
and contaminated syringe needles. The incubation period is about 30 days but can be
as long as 90 days. Since there can be a long
incubation period and insects are still active
through late fall, the best time to test for EIA
is during the winter months (January, February, March).
The EIA virus may occur in three different forms — acute, subacute and inapparent
(chronic). Symptoms of the acute form of the

disease would include extremely high temperature (104 to 108 F), depression, weakness, loss of appetite, drop in red blood cells
and even death. The subacute form would
show similar but less severe signs and seldom
death. The inapparent carrier may just appear
weak or unthrifty or may be very normal.

Summary
A disease control program can be tailormade not only for each horse farm but also for
each horse within the farm. The amount of
contact that one horse has with other horses
can greatly influence the need for appropriate
disease control. A recommended vaccination
program for horses in Tennessee is shown in
Table 1. Show horses, broodmares, foals and
backyard horses all have different requirements for disease control. Prevalence of a
disease in a certain locality or outbreak of a
disease can affect vaccination programs from
year to year. A local veterinarian can assist
the horse owner in developing a comprehensive disease control program.

Table 1: Vaccination Programs for Horses in Tennessee
A. Vaccination schedule for show horses
Spring
Tetanus
EEE and WEE
Influenza
Rhinopneumonitis
Potomac Horse Fever
Boosters required every 60 to 90 days
Influenza
Rhinopneumonitis
B. Vaccination schedule for broodmares
One month prior to foaling
Tetanus Toxoid
EEE and WEE
Influenza
Rhinopneumonitis
5th - 7th - 9th month of pregnancy

C.

Vaccination schedule for foals*
Birth
If the mare was vaccinated one month prior
to foaling and the foal received adequate
colostrum, no vaccination is required. If not,
tetanus toxoid and tetanus antitoxin should
be given at birth.
Third month
Tetanus, EEE and WEE, Influenza and
Rhinopneumonitis
Fourth month
Tetanus, EEE and WEE, Influenza and
Rhinopneumonitis

D.

Vaccination schedule for a backyard horse
with very little exposure to other horses
Annual
Tetanus Toxoid
EEE
WEE

* Booster Influenza and Rhinopneumonitis every 60 to 90 days
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